AVTR · Avantor, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-31 | Eck Steven W |
SVP & Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
1,385 |
| 2026-07-24 | Sokenu Claudius |
EVP, Chief Legal & Compliance |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
1,201 |
| 2026-06-21 | Walker Corey |
President, VWR Dist. & Servs. |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
3,010 |
| 2026-05-08 | LUCIER GREGORY T |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
10,000 |
| 2026-05-07 | MEHRA SANJEEV K |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 07, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | SUMME GREGORY L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 7, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | Murthy Mala |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 07, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | LUCIER GREGORY T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 7, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | Dingemans Simon |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 7, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | Massaro Joseph R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 07, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | Makin Louise |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 07, 2027. |
Common Stock
|
25,270 |
| 2026-05-07 | SEVERINO MICHAEL |
Vice Chairman |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 07, 2027. |
Common Stock
|
25,270 |
| 2026-05-01 | Brellier Ludovic |
EVP, Bioscience & Medtech |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on May 1, 2027. |
Common Stock
|
146,566 |
| 2026-05-01 | Dingemans Simon |
Director |
Buy↑
|
Common Stock
(I)
|
25,000 |
| 2026-05-01 | Brellier Ludovic |
EVP, Bioscience & Medtech |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on May 1, 2027. |
Stock Options (Right to Buy)
|
246,002 |
| 2026-05-01 | Brellier Ludovic |
EVP, Bioscience & Medtech |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-03 | Eck Steven W |
SVP & Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on April 3, 2027. |
Common Stock
|
31,645 |
| 2026-03-10 | MEHRA SANJEEV K |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $7.98 to $8.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. The Reporting Person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
125,000 |
| 2026-02-24 | Hankamer Brittany |
EVP, Chief HR Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
359 |
| 2026-02-24 | Eck Steven W |
SVP & Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
452 |
| 2026-02-23 | Eck Steven W |
SVP & Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
2,017 |
| 2026-02-23 | Hankamer Brittany |
EVP, Chief HR Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
1,324 |
| 2026-02-23 | Sokenu Claudius |
EVP, Chief Legal & Compliance |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
2,376 |
| 2026-02-23 | Gourdier Benoit |
EVP, Bioscience & Medtech |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
3,029 |
| 2026-02-23 | Jones R. Brent |
EVP, Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
2,805 |
| 2026-02-20 | Jones R. Brent |
EVP, Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
9,506 |
| 2026-02-20 | Walker Corey |
President, VWR Dist. & Servs. |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
4,963 |
| 2026-02-20 | Eck Steven W |
SVP & Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
2,125 |
| 2026-02-20 | Gourdier Benoit |
EVP, Bioscience & Medtech |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
4,160 |
| 2026-02-20 | Hankamer Brittany |
EVP, Chief HR Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
1,453 |
| 2026-02-20 | Sokenu Claudius |
EVP, Chief Legal & Compliance |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Common Stock
|
2,919 |
| 2026-02-19 | Ligner Emmanuel |
Director, President and CEO |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
1,903,847 |
| 2026-02-19 | Gourdier Benoit |
EVP, Bioscience & Medtech |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
528,848 |
| 2026-02-19 | Eck Steven W |
SVP & Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
48,859 |
| 2026-02-19 | Blenn Mary |
EVP, Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
235,993 |
| 2026-02-19 | Sokenu Claudius |
EVP, Chief Legal & Compliance |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
317,310 |
| 2026-02-19 | Eck Steven W |
SVP & Chief Accounting Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
43,230 |
| 2026-02-19 | Walker Corey |
President, VWR Dist. & Servs. |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
634,617 |
| 2026-02-19 | Walker Corey |
President, VWR Dist. & Servs. |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
161,237 |
| 2026-02-19 | Hankamer Brittany |
EVP, Chief HR Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
80,618 |
| 2026-02-19 | Jones R. Brent |
EVP, Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
161,237 |
| 2026-02-19 | Sokenu Claudius |
EVP, Chief Legal & Compliance |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
80,618 |
| 2026-02-19 | Ligner Emmanuel |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal installments beginning on February 19, 2027. |
Common Stock
|
483,713 |
| 2026-02-19 | Hankamer Brittany |
EVP, Chief HR Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
317,310 |
| 2026-02-19 | Blenn Mary |
EVP, Chief Operating Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
1,041,766 |
| 2026-02-19 | Jones R. Brent |
EVP, Chief Financial Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. |
Stock Options (Right to Buy)
|
634,617 |
| 2026-02-19 | Gourdier Benoit |
EVP, Bioscience & Medtech |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. |
Common Stock
|
134,364 |
| 2026-02-19 | LUCIER GREGORY T |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $9.06 to $9.25, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
50,000 |
| 2026-02-12 | SUMME GREGORY L |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
By a trust. The reporting person reports beneficial ownership of AVTR common stock held by the trust but disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
100,000 |
| 2026-01-02 | Dingemans Simon |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units that vests on May 6, 2026. |
Common Stock
|
6,225 |